Form 4: Teladoc Health Director Kenneth Paulus Acquires Restricted Stock Units

Director Kenneth Paulus acquired 17,467 restricted stock units in Teladoc Health, Inc. on May 23, 2024, which will vest on the earlier of May 23, 2025, or the day before the 2025 annual meeting of stockholders.

Summary

• On May 23, 2024, Kenneth H. Paulus, a director of Teladoc Health, Inc., acquired 17,467 restricted stock units (RSUs).
• These RSUs represent a contingent right to receive one share of TDOC common stock each.
• The RSUs will vest in full on the earlier of May 23, 2025, or the day immediately preceding the issuer's 2025 annual meeting of stockholders.
• Vested shares will be delivered under specific conditions, including separation of service, a change of control, or the reporting person's death.

Sentiment

Score: 6

Explanation: The document is a standard SEC filing related to stock options. It doesn't contain overtly positive or negative information, but the granting of stock options to a director is generally viewed as a neutral to slightly positive sign.

Positives

• The acquisition of restricted stock units by a director signals confidence in the company's future performance.

Future Outlook

The vesting of the restricted stock units is tied to future events, including the 2025 annual meeting and potential separation of service or change of control.

Industry Context

This filing is a routine disclosure of stock-based compensation for a company director, common in publicly traded companies to align management interests with shareholder value.

Stakeholder Impact

• Shareholders may view the acquisition of restricted stock units by a director as a positive sign, aligning the director's interests with the company's performance.

Key Dates